Physician profile
Ryan S Jackson
NPI 1710114582
$284,204.13
in general payments reported to CMS, 2019-2025
8 companies · $47K in 2025
The $47K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,967 · 2020: $63K · 2021: $87K · 2022: $41K · 2023: $16K · 2024: $28K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $83K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Travel and Lodging: $1,698 · Food and Beverage: $1,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $83,300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Travel and Lodging | $1,698.44 |
| Food and Beverage | $1,392.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $282,483.98 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Inspire Medical Systems, INC. | $1,475.68 | 2019-2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $115.00 | 2019 | |
| Galderma Laboratories, L.P. | $44.28 | 2019-2025 | Nemluvio |
| Lilly USA, LLC | $32.39 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $21.98 | 2019 | |
| Olympus America INC. | $17.90 | 2019 | |
| Sun Pharmaceutical Industries INC. | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.